T. Rowe Price Associates’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$460K Buy
17,798
+706
+4% +$18.2K ﹤0.01% 2344
2025
Q1
$175K Buy
17,092
+4,227
+33% +$43.3K ﹤0.01% 2694
2024
Q4
$180K Buy
12,865
+729
+6% +$10.2K ﹤0.01% 2715
2024
Q3
$237K Hold
12,136
﹤0.01% 2580
2024
Q2
$226K Buy
12,136
+3,819
+46% +$71.1K ﹤0.01% 2544
2024
Q1
$117K Hold
8,317
﹤0.01% 2752
2023
Q4
$71K Hold
8,317
﹤0.01% 2761
2023
Q3
$75K Buy
8,317
+3,874
+87% +$34.9K ﹤0.01% 2707
2023
Q2
$39K Sell
4,443
-14,735
-77% -$129K ﹤0.01% 2823
2023
Q1
$203K Buy
19,178
+1,986
+12% +$21K ﹤0.01% 2519
2022
Q4
$583K Sell
17,192
-250
-1% -$8.48K ﹤0.01% 2062
2022
Q3
$838K Sell
17,442
-1,175
-6% -$56.5K ﹤0.01% 1846
2022
Q2
$1.06M Buy
18,617
+11,685
+169% +$666K ﹤0.01% 1866
2022
Q1
$560K Buy
6,932
+669
+11% +$54K ﹤0.01% 2280
2021
Q4
$1.27M Sell
6,263
-2,180
-26% -$442K ﹤0.01% 1910
2021
Q3
$2.28M Sell
8,443
-25,821
-75% -$6.96M ﹤0.01% 1672
2021
Q2
$8.82M Sell
34,264
-1,214
-3% -$312K ﹤0.01% 1430
2021
Q1
$10.6M Sell
35,478
-1,115
-3% -$334K ﹤0.01% 1383
2020
Q4
$9.33M Sell
36,593
-37,958
-51% -$9.68M ﹤0.01% 1355
2020
Q3
$18.6M Sell
74,551
-11,542
-13% -$2.87M ﹤0.01% 1173
2020
Q2
$29.9M Sell
86,093
-7,548
-8% -$2.62M ﹤0.01% 1014
2020
Q1
$25.1M Buy
93,641
+27,971
+43% +$7.49M ﹤0.01% 996
2019
Q4
$21.3M Sell
65,670
-32,284
-33% -$10.5M ﹤0.01% 1163
2019
Q3
$26.8M Buy
97,954
+9,719
+11% +$2.66M ﹤0.01% 1061
2019
Q2
$47.1M Sell
88,235
-4,863
-5% -$2.6M 0.01% 913
2019
Q1
$46.9M Sell
93,098
-8,983
-9% -$4.53M 0.01% 904
2018
Q4
$50.3M Sell
102,081
-16,202
-14% -$7.99M 0.01% 817
2018
Q3
$108M Sell
118,283
-10,002
-8% -$9.15M 0.02% 647
2018
Q2
$94M Sell
128,285
-82,264
-39% -$60.3M 0.01% 681
2018
Q1
$336M Buy
210,549
+87,174
+71% +$139M 0.05% 346
2017
Q4
$111M Buy
123,375
+44,908
+57% +$40.2M 0.02% 609
2017
Q3
$28.2M Buy
78,467
+11,832
+18% +$4.26M ﹤0.01% 1059
2017
Q2
$19.5M Sell
66,635
-19,182
-22% -$5.63M ﹤0.01% 1181
2017
Q1
$30.2M Buy
85,817
+4,570
+6% +$1.61M 0.01% 994
2016
Q4
$15M Buy
81,247
+4,154
+5% +$765K ﹤0.01% 1224
2016
Q3
$19.9M Buy
77,093
+38,126
+98% +$9.83M ﹤0.01% 1130
2016
Q2
$8.32M Buy
38,967
+7,040
+22% +$1.5M ﹤0.01% 1318
2016
Q1
$6.59M Buy
31,927
+3,447
+12% +$711K ﹤0.01% 1344
2015
Q4
$7.2M Buy
28,480
+3,267
+13% +$826K ﹤0.01% 1354
2015
Q3
$4.15M Buy
25,213
+600
+2% +$98.6K ﹤0.01% 1461
2015
Q2
$4.62M Sell
24,613
-327
-1% -$61.4K ﹤0.01% 1495
2015
Q1
$4.12M Sell
24,940
-3,454
-12% -$570K ﹤0.01% 1497
2014
Q4
$6.6M Buy
28,394
+5,507
+24% +$1.28M ﹤0.01% 1424
2014
Q3
$4.14M Buy
22,887
+787
+4% +$142K ﹤0.01% 1485
2014
Q2
$4.25M Sell
22,100
-70,793
-76% -$13.6M ﹤0.01% 1478
2014
Q1
$16.9M Sell
92,893
-2,907
-3% -$528K ﹤0.01% 1161
2013
Q4
$16.3M Buy
95,800
+733
+0.8% +$125K ﹤0.01% 1148
2013
Q3
$14.9M Sell
95,067
-5,860
-6% -$919K ﹤0.01% 1163
2013
Q2
$17.5M Buy
+100,927
New +$17.5M ﹤0.01% 1099